Genetic disorders and renal cell carcinoma

被引：7

作者：

Maranchie, JK ^{[1
]}

Linehan, WM ^{[1
]}

机构：

[1] NCI, Urol Oncol Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA

来源：

UROLOGIC CLINICS OF NORTH AMERICA | 2003年 / 30卷 / 01期

关键词：

D O I：

10.1016/S0094-0143(02)00120-9

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Familial syndromes have been described for each of the common renal cell carcinoma histologies. Analysis of affected families led to the identification of genes that are involved in sporadic renal cell carcinoma, and continues to provide insight into the cellular pathways that are associated with tumorigenesis. Because hereditary renal carcinoma frequently has an early-onset and is multi-focal, patient management involves life-long screening and measures to minimize the frequency of invasive procedures and preserve renal parenchyma. An awareness of the nonrenal manifestations of these genetic disorders may facilitate prompt diagnosis and appropriate intervention.

引用

页码：133 / +

页数：10

共 50 条

[1]

[Anonymous], 1926, ActaPatholMicrobiolScandSuppl

[2] Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity [J].

Blankenship, C ;

Naglich, JG ;

Whaley, JM ;

Seizinger, B ;

Kley, N .

ONCOGENE, 1999, 18 (08) :1529-1535

[3] Role of exon 2-encoded β-domain of the von Hippel-Lindau tumor suppressor protein [J].

Bonicalzi, ME ;

Groulx, I ;

de Paulsen, N ;

Lee, S .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :1407-1416

[4] Renal involvement in von Hippel-Lindau disease [J].

Chauveau, D ;

Duvic, C ;

Chretien, Y ;

Paraf, F ;

Droz, D ;

Melki, P ;

Helenon, O ;

Richard, S ;

Grunfeld, JP .

KIDNEY INTERNATIONAL, 1996, 50 (03) :944-951

[5] GERMLINE MUTATIONS IN THE VONHIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE - CORRELATIONS WITH PHENOTYPE [J].

CHEN, F ;

KISHIDA, T ;

YAO, M ;

HUSTAD, T ;

GLAVAC, D ;

DEAN, M ;

GNARRA, JR ;

ORCUTT, ML ;

DUH, FM ;

GLENN, G ;

GREEN, J ;

HSIA, YE ;

LAMIELL, J ;

LI, H ;

WEI, MH ;

SCHMIDT, L ;

TORY, K ;

KUZMIN, I ;

STACKHOUSE, T ;

LATIF, F ;

LINEHAN, WM ;

LERMAN, M ;

ZBAR, B .

HUMAN MUTATION, 1995, 5 (01) :66-75

[6] MISCELLANEOUS GENODERMATOSES - BECKWITH-WIEDEMANN SYNDROME, BIRT-HOGG-DUBE SYNDROME, FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA SYNDROME, HEREDITARY TYLOSIS, INCONTINENTIA PIGMENTI, AND SUPERNUMERARY NIPPLES [J].

COHEN, PR ;

KURZROCK, R .

DERMATOLOGIC CLINICS, 1995, 13 (01) :211-229

[7] The Elongin BC complex and the von Hippel-Lindau tumor suppressor protein [J].

Conaway, JW ;

Kamura, T ;

Conaway, RC .

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1998, 1377 (02) :M49-M54

[8]

Cushing H, 1928, ARCH OPHTHALMOL-CHIC, V57, P447

[9] Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes [J].

Eisenhofer, G ;

Walther, MM ;

Huynh, TT ;

Li, ST ;

Bornstein, SR ;

Vortmeyer, A ;

Mannelli, M ;

Goldstein, DS ;

Linehan, WM ;

Lenders, JWM ;

Pacak, K .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05) :1999-2008

[10] MUTATIONS OF THE VHL TUMOR-SUPPRESSOR GENE IN RENAL-CARCINOMA [J].

GNARRA, JR ;

TORY, K ;

WENG, Y ;

SCHMIDT, L ;

WEI, MH ;

LI, H ;

LATIF, F ;

LIU, S ;

CHEN, F ;

DUH, FM ;

LUBENSKY, I ;

DUAN, DR ;

FLORENCE, C ;

POZZATTI, R ;

WALTHER, MM ;

BANDER, NH ;

GROSSMAN, HB ;

BRAUCH, H ;

POMER, S ;

BROOKS, JD ;

ISAACS, WB ;

LERMAN, MI ;

ZBAR, B ;

LINEHAN, WM .

NATURE GENETICS, 1994, 7 (01) :85-90

← 1 2 3 4 5 →